Literature DB >> 6262830

Locations of adenovirus genes required for the replication of adenovirus-associated virus.

J E Janik, M M Huston, J A Rose.   

Abstract

We have used DNA transfection to identify several regions of the adenovirus genome needed to induce replication of the defective parvovirus, adenovirus-associated virus (AAV). Previous studies have indicated that only early adenovirus functions are needed to aid the replication of AAV. In this report, we demonstrate that three restriction endonuclease fragments of adenovirus DNA are necessary for production of infectious AAV in 293-31 cells (an adenovirus type 5-transformed human embryonic kidney cell line). These fragments map from 28.5 to 29.4, 59.5 to 75.9, and 89.7 to 100 map units on the adenovirus type 2 genome and correspond to the locations of the VAI RNA gene, early region 2, and early region 4, respectively. The 293-31 cell line, which has been found to express early region 1A and 1B proteins, alone is incapable of supporting AAV replication or even AAV DNA synthesis. Additional experiments with adenovirus type 5 host range mutants (group I, hr1 and group II, hr7) indicate, however, that early region 1A provides an essential function(s) for AAV replication, whereas early region 1B probably does not.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262830      PMCID: PMC319248          DOI: 10.1073/pnas.78.3.1925

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Temperature-sensitive replication of H5ts125 adenovirus DNA in vitro.

Authors:  M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Evidence for a function of the adenovirus DNA-binding protein in initiation in DNA synthesis as well as in elongation of nascent DNA chains.

Authors:  P C Van der Vliet; J Zandberg; H S Jansz
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

3.  Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication.

Authors:  B J Carter; F J Koczot; J Garrison; J A Rose; R Dolin
Journal:  Nat New Biol       Date:  1973-07-18

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Biochemical studies on adenovirus multiplication. XIV. Macromolecule and enzyme synthesis in cells replicating oncogenic and nononcogenic human adenovirus.

Authors:  M Piña; M Green
Journal:  Virology       Date:  1969-08       Impact factor: 3.616

6.  Definition of a novel promoter for the major adenovirus-associated virus mRNA.

Authors:  M R Green; R G Roeder
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

7.  A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2.

Authors:  H Söderlund; U Pettersson; B Vennström; L Philipson; M B Mathews
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

8.  DNA-minus temperature-sensitive mutants of adenovirus type 5 help adenovirus-associated virus replication.

Authors:  S E Straus; H S Ginsberg; J A Rose
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

9.  Low molecular weight viral RNAs transcribed by RNA polymerase III during adenovirus 2 infection.

Authors:  R Weinmann; T G Brendler; H J Raskas; R G Roeder
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

10.  Adenovirus-associated virus multiplication. VII. Helper requirement for viral deoxyribonucleic acid and ribonucleic acid synthesis.

Authors:  J A Rose; F Koczot
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

View more
  39 in total

Review 1.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

2.  The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation.

Authors:  R Reichel; S D Neill; I Kovesdi; M C Simon; P Raychaudhuri; J R Nevins
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs.

Authors:  R J Samulski; T Shenk
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA.

Authors:  H Ashktorab; A Srivastava
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Identification of an adeno-associated virus Rep protein binding site in the adenovirus E2a promoter.

Authors:  John M Casper; Jennifer M Timpe; John David Dignam; James P Trempe
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Requirement for either early region 1a or early region 1b adenovirus gene products in the helper effect for adeno-associated virus.

Authors:  W D Richardson; H Westphal
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

7.  Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants.

Authors:  P L Hermonat; M A Labow; R Wright; K I Berns; N Muzyczka
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  Expression of cloned herpesvirus genes. I. Detection of nuclear antigens from herpes simplex virus type 2 inverted repeat regions in transfected mouse cells.

Authors:  M H Middleton; G R Reyes; D M Ciufo; A Buchan; J C Macnab; G S Hayward
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  Adeno-associated virus helper activity of adenovirus DNA binding protein.

Authors:  R A McPherson; H S Ginsberg; J A Rose
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

10.  The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication.

Authors:  Travis H Stracker; Geoffrey D Cassell; Peter Ward; Yueh-Ming Loo; Bas van Breukelen; Stacy D Carrington-Lawrence; Robert K Hamatake; Peter C van der Vliet; Sandra K Weller; Thomas Melendy; Matthew D Weitzman
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.